Compare UHAL & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UHAL | NUWE |
|---|---|---|
| Founded | 1945 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Rental/Leasing Companies | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 2.9M |
| IPO Year | N/A | N/A |
| Metric | UHAL | NUWE |
|---|---|---|
| Price | $53.40 | $2.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 170.9K | 39.7K |
| Earning Date | 02-04-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.19 | N/A |
| Revenue | ★ $5,972,459,000.00 | $8,167,999.00 |
| Revenue This Year | $6.61 | N/A |
| Revenue Next Year | $4.20 | $10.48 |
| P/E Ratio | $44.67 | ★ N/A |
| Revenue Growth | ★ 5.86 | N/A |
| 52 Week Low | $48.48 | $1.71 |
| 52 Week High | $75.19 | $70.14 |
| Indicator | UHAL | NUWE |
|---|---|---|
| Relative Strength Index (RSI) | 58.09 | 44.64 |
| Support Level | $50.08 | $1.71 |
| Resistance Level | $51.81 | $2.20 |
| Average True Range (ATR) | 1.11 | 0.15 |
| MACD | 0.14 | 0.00 |
| Stochastic Oscillator | 93.92 | 51.80 |
U-Haul Holding Co is an American moving truck, trailer, and self-storage rental company. The company also provides moving boxes, packing supplies, LPG (propane) refills, trailer hitch and wiring installation, storage container rentals, and other services. It has three reportable segments Moving and Storage, Property and Casualty Insurance, and Life Insurance. The majority of its revenue comes from the Moving and Storage segment.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.